Loading clinical trials...
Loading clinical trials...
There are two principal purposes of this study: 1) to determine whether it is more beneficial for a liver transplant recipient candidate to pursue a living donor liver transplant (LDLT) or wait for a ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Arbor Research Collaborative for Health
Collaborators
NCT06345547 · Sarcopenia, Cirrhosis, and more
NCT06902246 · Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma
NCT07069725 · Liver Fibrosis, Hepatic Cirrhosis
NCT07422753 · Hepatocellular Carcinoma (HCC)
NCT07175441 · Advanced Unresectable Hepatocellular Carcinoma
University of California Los Angeles
Los Angeles, California
University of California San Francisco
San Francisco, California
University of Colorado Health System
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions